Olympus Korea will discontinue its camera business on June 30 due to low profitability and will shift its focus on medical equipment and science solutions.
The Korean unit of the Japan-headquartered firm that makes optics and photography products will also close its store and online shopping mall next month.
Olympus Korea will keep operating the service facility for repairing and exchanging products until March 31, 2026.
The company tried to improve its profitability with mirrorless cameras and interchangeable lenses, but as South Korea's camera market shrank considerably, it had to withdraw from the business.
Among Olympus Korea's other offerings are endoscopy and surgical equipment and microscopes.
The company has a medical training and education center in Incheon, which it opened in 2017.
Olympus Korea denied that their decision is in support of an ongoing anti-Japan sentiment and boycott all Japanese products in South Korea.


GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook
Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations
BHP, Port Hedland Unions Fail to Reach Wage Deal as Negotiations Continue
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs
Sika Raises 2026 Sales Outlook After Strong First-Half Results Beat Expectations 



